0FRD87Z
Replacement Pancreatic Duct to No Qualifier with Autologous Tissue Substitute, Via Natural or Artificial Opening Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | R Replacement |
| Body Part | D Pancreatic Duct |
| Approach | 8 Via Natural or Artificial Opening Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically takes the place and/or function of all or a portion of a body part
Procedure Overview
Replacement procedures in this body system involve putting in biological or synthetic material that physically takes over for hepatobiliary or pancreatic tissue that has been removed or has failed. This is less common here than in joints or vessels, but it appears in cases such as reconstructing a resected segment of common bile duct with a synthetic conduit, or substituting a portion of the biliary tree with harvested tissue when the native duct cannot be repaired or reconnected directly.
The goal is to restore the physical pathway or structural function that the original tissue provided, most often maintaining bile flow from the liver to the intestine after injury, tumor removal, or failed prior surgery. Because these are structurally significant reconstructions, they're typically performed as part of a larger operation rather than as standalone procedures.
Anatomy & Axis Detail
Pancreatic Duct
The pancreatic duct, or duct of Wirsung, runs the length of the gland collecting exocrine secretions and delivering them toward the ampulla of Vater, and its patency is essential to normal digestion. Replacement of this structure involves removing a damaged or diseased ductal segment, such as one destroyed by chronic pancreatitis, stricture, or trauma, and substituting a graft or synthetic conduit to restore continuity of enzyme drainage. This differs from simple drainage procedures or anastomotic bypass in that an actual segment of the duct's tubular architecture is taken out and replaced with nonautologous or biologic material. Coders should confirm that the operative note describes excision of the ductal segment with insertion of a substitute channel, not merely a side-to-side diversion of pancreatic flow.
Approach: Via Natural or Artificial Opening Endoscopic
Via Natural or Artificial Opening Endoscopic describes instrumentation introduced through a natural orifice or a surgically created opening while using an endoscope for visualization, as in a routine colonoscopy performed through the anus. It differs from the plain Via Natural or Artificial Opening value by the added scope, and from Percutaneous Endoscopic by using an existing passage rather than a new skin puncture.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders should look for explicit documentation that a graft, conduit, or other material was used to physically stand in for tissue that was excised or was not repairable in place. The operative report needs to state what was removed, what material replaced it, and where it was anastomosed. A common mistake is coding Replacement when the surgeon actually reconstructed continuity using the patient's own repositioned tissue, such as a Roux-en-Y hepaticojejunostomy, which is typically coded differently since bowel is being connected rather than biliary tissue being replaced. Confirming the material type (autograft, synthetic, or nonautologous) also matters for accurate device character assignment.